Patent Assignment
Reel/Frame 021232/0787
Confirmatory License
Recorded: 2008-07-14
Pages: 2
Assignor
DANA-FARBER CANCER INSTITUTE
Executed: 2001-01-29
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Method of Using Sfv HUTAT2 in Intracellular Targeting Generation of Ln-Hsfvtat Packaging Cell Lines
Patent:
6,479,284 →
Application:
09/660,169 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 14, 2000
From: MARASCO, WAYNE A.; LAVECCHIO, JOYCE; MHASHILKAR, ABNER M.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 011340/0597 →
Assignment of Assignor's Interest
Dec 14, 2000
From: DAVID, RING
To: CHIRON CORPORATION
Reel/Frame 011340/0618 →
Assignment of Assignor's Interest
Jun 15, 2001
From: RAMSTEDT, URBAN; EBERHARDT, BRIDGET; PORTER-BROOKS, JULIE
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 011901/0711 →
Change of Name
Mar 9, 2009
From: AVANT IMMUNOTHERAPEUTICS, INC. (NEEDHAM, MASSACHUSETTS)
To: CELLDEX THERAPEUTICS, INC.
Reel/Frame 022380/0239 →
Confirmatory License
Sep 27, 2016
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 039868/0084 →